Jazz Pharmaceuticals plc ( JAZZ) - Stock Earnings
JAZZ Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
JAZZ Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 203.5 million USD | 1.2 billion USD |
| 2026Q1 | 293.1 million USD | 1.1 billion USD |
| 2026Q2 | 192.8 million USD | 1.2 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
JAZZ Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 414.8 million USD | 3.8 billion USD |
| 2024 | 560.1 million USD | 4.1 billion USD |
| 2025 | -356.1 million USD | 4.3 billion USD |
| 2026 Est. | — | — |
JAZZ
Price: $211.14
Earnings Per Share: 14.62 USD
P/E Ratio: 17.55
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Ireland
Volume: 468012
Ebitda: 136.8 millionMarket Capitalization: 14.8 billion